Figure S4. Ingenuity network analysis, networks with highest scores. Networks were scored based on the number of network eligible molecules they contained. Network eligible molecules with relatively increased expression are shown in red, whereas molecules with relatively reduced expression are shown in green. The intensity of the color is proportional to the fold change. Non-colored nodes represent genes added by Ingenuity pathway analysis based on its network algorithm but not upregulated in the actual microarray data. A. Network “Connective tissue disease, organismal injury and abnormality, cancer” (score = 29). Network eligible molecules with relatively increased expression in the IPF group are shown in red, whereas molecules with relati...
WGCNA identifies cutaneous gene modules. (A) Hierarchical clustering of samples prior to network gen...
Table S1. Genes: Table of the 20 most significantly differentially expressed genes. KW_treated and K...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Figure S3. Comparison of gene expression levels determined by oligonucleotide microarray (left) and ...
Figure S1. A. Probe intensity histogram. B. F ratio: signal-to-noise ratio, IPF vs. NSIP analysis ac...
Table S1. Top 25 upregulated genes in IPF vs. control (SAM analysis). Table S2. IPF vs. control, Ing...
Figure S2. Principal component analysis, a global analysis across the whole genome. IPF and NSIP gro...
Figure S1. Gene expression profiles in lung tissues taken from IPF patients were highly heterogeneou...
Figure S2. Ingenuity pathway analysis identifies protein networks showing inter-relationships and pa...
Gene interaction network of IPF prognostic predictor genes. Significant gene interaction networks we...
Additional file 1. Figure S1. Acquisition of candidate genes and their expression patterns across th...
Impaired Diversity of the Lung Microbione Predicts Progression of Idiopathic pulmonary Fibrosis. Tab...
Text S1. Materials and data collection. Text S2. Details of smoothing and Feature Topology Plots (FT...
Detailed results of NanoString nCounter validation. Upper 3 panels. Microarrays Log2(FC) IPF vs cont...
Figure S2. Scatter plots of gene expression levels of selected molecular markers with their protein ...
WGCNA identifies cutaneous gene modules. (A) Hierarchical clustering of samples prior to network gen...
Table S1. Genes: Table of the 20 most significantly differentially expressed genes. KW_treated and K...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Figure S3. Comparison of gene expression levels determined by oligonucleotide microarray (left) and ...
Figure S1. A. Probe intensity histogram. B. F ratio: signal-to-noise ratio, IPF vs. NSIP analysis ac...
Table S1. Top 25 upregulated genes in IPF vs. control (SAM analysis). Table S2. IPF vs. control, Ing...
Figure S2. Principal component analysis, a global analysis across the whole genome. IPF and NSIP gro...
Figure S1. Gene expression profiles in lung tissues taken from IPF patients were highly heterogeneou...
Figure S2. Ingenuity pathway analysis identifies protein networks showing inter-relationships and pa...
Gene interaction network of IPF prognostic predictor genes. Significant gene interaction networks we...
Additional file 1. Figure S1. Acquisition of candidate genes and their expression patterns across th...
Impaired Diversity of the Lung Microbione Predicts Progression of Idiopathic pulmonary Fibrosis. Tab...
Text S1. Materials and data collection. Text S2. Details of smoothing and Feature Topology Plots (FT...
Detailed results of NanoString nCounter validation. Upper 3 panels. Microarrays Log2(FC) IPF vs cont...
Figure S2. Scatter plots of gene expression levels of selected molecular markers with their protein ...
WGCNA identifies cutaneous gene modules. (A) Hierarchical clustering of samples prior to network gen...
Table S1. Genes: Table of the 20 most significantly differentially expressed genes. KW_treated and K...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...